-
Case of the month from the Department of Medical Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Australia: recurrent metastatic spermatocytic tumour successfully treated with salvage systemic chemotherapy BJU Int. (IF 4.5) Pub Date : 2024-05-15 Jane McKenzie, Catherine Mitchell, Jeremy Lewin, Ciara Conduit
Introduction Spermatocytic tumours are a rare subtype of testicular neoplasm and represent less than 1% of all testicular neoplasms. They generally display indolent biology and therefore commonly present as large testicular masses. Despite this, and in contrast to invasive germ cell tumours, spermatocytic tumours are rarely pT2 (i.e., rarely involve the tunica vaginalis or display lymphovascular invasion)
-
Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective ‘ablate-and-resect’ study BJU Int. (IF 4.5) Pub Date : 2024-05-14 Alexandre Peltier, Roland van Velthoven, Arthur Baudewyns, Grégoire Assenmacher, Marc Lemort, Yolene Lefebvre, Nicolas Sirtaine, Romain Diamand
To assess histopathological outcomes, as well as feasibility and safety of targeted microwave ablation (TMA) via the Trinity® system (KOELIS, La Tronche, France).
-
Grid-based cognitive diagnostic prostatic biopsy without transrectal ultrasonography BJU Int. (IF 4.5) Pub Date : 2024-05-13 Dhruv Satya Sahni, John Morrison, Hing Y. Leung
Introduction Prostate and colorectal cancers are the second and third most common malignancies affecting men globally [1]. Abdominoperineal resection is the standard of care surgical treatment for patients with malignancy of the distal rectum or anal canal, while pan-proctocolectomy may be indicated for patients with inflammatory bowel disease and familial adenomatous polyposis [2]. Both these procedures
-
A review of vitamin use for the prevention or treatment of prostate cancer BJU Int. (IF 4.5) Pub Date : 2024-05-14 David J. Benjamin, Omid Yazdanpanah, Arash Rezazadeh Kalebasty
-
Transnational telesurgery performed with the new robot‐assisted flexible ureteroscopy system BJU Int. (IF 4.5) Pub Date : 2024-05-11 Guangdi Chu, Xuecheng Yang, Wei Jiao, Jianchang Zhao, Bo Guan, Yuan Gao, Shuxin Wang, Jianmin Li, Haitao Niu
-
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review BJU Int. (IF 4.5) Pub Date : 2024-05-11 Jakob Klemm, Daniel R. Stelzl, Robert J. Schulz, Phillip Marks, Shahrokh F. Shariat, Margit Fisch, Roland Dahlem, Malte W. Vetterlein
ObjectiveTo investigate long‐term and patient‐reported outcomes, including sexual function, in women undergoing urogenital fistula (UGF) repair, addressing the lack of such data in Western countries, where fistulas often result from iatrogenic causes.Patients and MethodsWe conducted a retrospective analysis at a tertiary referral centre (2010–2023), classifying fistulas based on World Health Organisation
-
-
Prostate cancer: To screen, or not to screen? That is the question BJU Int. (IF 4.5) Pub Date : 2024-05-10
-
-
Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer BJU Int. (IF 4.5) Pub Date : 2024-05-10 Niko Pasanen, Kirsi Talala, Sebastiaan Remmers, Teuvo L. J. Tammela, Jonas Hugosson, Monique J. Roobol, Kimmo Taari, Rebecka Arnsrud Godtman, Chris Bangma, Anssi Auvinen
ObjectiveTo evaluate whether a subgroup of men can be identified that would benefit more from screening than others.Materials and MethodsThis retrospective cohort study was based on three European Randomised Study of Screening for Prostate Cancer (ERSPC) centres, Finland, the Netherlands and Sweden. We identified 126 827 men aged 55–69 years in the study who were followed for maximum of 16 years after
-
One‐year outcomes of same‐day‐discharge robot‐assisted radical prostatectomy BJU Int. (IF 4.5) Pub Date : 2024-05-08 Alae Touzani, Daniele D'Agate, Claudia Kesch, Giorgio Calleris, Bogdan Buhas, Rawad Abou‐Zahr, Razvan‐George Rahota, Adil Ouzzane, Benjamin Pradère, Christophe Tollon, Alberto Martini, Guillaume Ploussard
-
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor BJU Int. (IF 4.5) Pub Date : 2024-05-08 Maximilian Haas, Maximilian C. Kriegmair, Johannes Breyer, Danijel Sikic, Felix Wezel, Florian Roghmann, Mirco Brehmer, Ralph M. Wirtz, Jonas Jarczyk, Philipp Erben, Veronika Bahlinger, Franziska Goldschmidt, Guido Fechner, Jack Chen, Ellen Paxinos, Michael Bates, Friedemann Zengerling, Christian Bolenz, Maximilian Burger, Arndt Hartmann, Markus Eckstein
ObjectiveTo investigate and compare the performance of urinary cytology and the Xpert BC Monitor test in the detection of bladder cancer in various clinically significant patient cohorts, including patients with carcinoma in situ (CIS), in a prospective multicentre setting, aiming to identify potential applications in clinical practice.Patients and MethodsA total of 756 patients scheduled for transurethral
-
Case of the month from the Desai Sethi Urology Institute, Florida, USA: bladder outlet obstruction‐induced urinothorax after percutaneous nephrolithotomy BJU Int. (IF 4.5) Pub Date : 2024-05-08 Ryan Chen, Joao G. Porto, Ruben Blachman‐Braun, Diana M. Lopategui, Robert Marcovich, Hemendra N. Shah
Introduction Urinothorax, a rare cause of pleural effusion characterised by the presence of urine in the pleural space, typically occurs iatrogenically after urological procedures or spontaneously due to obstructive uropathies. Its diagnosis centres on high clinical suspicion and the biochemical analysis of pleural fluid, with treatment focusing on alleviating urinary obstruction or treating traumatic
-
-
Abstracts from the Caribbean Urological Association 25th Annual International Conference, November 3rd–5th, 2023; Port of Spain, Trinidad, West Indies BJU Int. (IF 4.5) Pub Date : 2024-05-07
Clinicopathological profile of prostate cancer at a tertiary institution in Trinidad J De Gannes, S Mohammed, A Singh, K Gooden Port of Spain General Hospital, Trinidad and Tobago Objectives: To examine the cross sectional clinical and pathological profile of prostate biopsies of all patients attending the Port of Spain General Hospital over a period of 1 year from January 2020 to January 2021. Methodology:
-
Author Index BJU Int. (IF 4.5) Pub Date : 2024-05-07
Ahamad, 10 Aji, S, 8 Anwar, A, 9 Bajrangee, G, 14 Bandoo, V, 6, 7 Barker, J, 13 Baron, J, 7 Bayo, O, 13 Bhagaloo, V, 11 Bhagwandeen, B, 12 Burnett, AL, 8, 12 Cathcart, P, 10 Challacombe, B, 6 Clark, C, 9 Cooblal, AS, 8 De Gannes, J, 4 Depeiza, N, 13 Furrer, M, 10 Ghazi, A, 8 Goetz, L, 12, 14 Gooden, K, 4, 12 Goordeen, D, 13 Gosein, S, 9, 14 Guest, K, 9 Hage, O.El, 10 Harrykissoon, K, 14 Hassan, M,
-
Evaluation of radiation exposure to the gonads of urologists during seated lithotripsy procedures BJU Int. (IF 4.5) Pub Date : 2024-05-01 Duncan Self, Jennifer Diffey, Anders Bergersen, Nicholas McLeod, Avi Raman
-
Case of the month from the Department of Urology, Addenbrookes Hospital, Cambridge, UK: clinical perinephric haematoma after shock wave lithotripsy: a rare but significant complication BJU Int. (IF 4.5) Pub Date : 2024-04-30 Sindhu Sankaran, Andrew Winterbottom, Oliver Wiseman
-
Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system BJU Int. (IF 4.5) Pub Date : 2024-04-29 Kelly K. Bree, Jessica L. Janes, Patrick J. Hensley, Aditya Srinivasan, Amanda M. De Hoedt, Sanjay Das, Stephen J. Freedland, Stephen B. Williams
ObjectiveTo describe patient characteristics and pathological stage at bladder cancer (BCa) diagnosis in a diverse population within a national, equal‐access healthcare system.MethodsThis retrospective cohort study identified 15 966 men diagnosed with BCa in the Veterans Affairs (VA) healthcare system from 2000 to 2020. The primary outcome was pathological stage at diagnosis, determined by index transurethral
-
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia BJU Int. (IF 4.5) Pub Date : 2024-04-28 Maciej Jacewicz, Erik Rud, Peter Lauritzen, Eduard Baco
ObjectiveTo report non‐infectious adverse events associated with transperineal prostate biopsy (TPBx) performed under local anaesthesia (LA) in an outpatient setting.Patients and methodsThis study reports secondary outcomes from the Norwegian arm of the prospective NORAPP study (ClinicalTrials.gov identifier NCT04146142) and included all patients referred for prostate biopsy from November 2019 to February
-
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function BJU Int. (IF 4.5) Pub Date : 2024-04-26 Christian D. Fankhauser, Christian Malkmus, Fabian Aschwanden, Philipp Baumeister, Agostino Mattei
Introduction Robot-assisted radical prostatectomy (RARP) is a treatment option for men with localised prostate cancer. The challenge of RARP consists in competing oncological and functional goals. The most common side effects following RARP are urinary incontinence and erectile dysfunction, occurring in 74% and 79%, respectively, of participants in the PROTECT study, a prospective randomised trial
-
First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy BJU Int. (IF 4.5) Pub Date : 2024-04-25 Takafumi Yanagisawa, Tatsushi Kawada, Kensuke Bekku, Ekaterina Laukhtina, Pawel Rajwa, Markus von Deimling, Marcin Chlosta, Fahad Quhal, Benjamin Pradere, Pierre I. Karakiewicz, Keiichiro Mori, Takahiro Kimura, Shahrokh F. Shariat, Manuela Schmidinger
ObjectiveTo compare the differential efficacy of first‐line immune checkpoint inhibitor (ICI)‐based combined therapies among patients with intermediate‐ and poor‐risk metastatic renal cell carcinoma (mRCC), as recently, the efficacy of triplet therapy comprising nivolumab plus ipilimumab plus cabozantinib has been published.Patients and MethodsThree databases were searched in December 2022 for randomised
-
Surveillance of non‐muscle‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis BJU Int. (IF 4.5) Pub Date : 2024-04-25 Reza Sari Motlagh, Alireza Ghoreifi, Takafumi Yanagisawa, Tatsushi Kawada, Sascha Ahyai, Axel S. Merseburger, Mohammad Abufaraj, Michael Abern, Hooman Djaladat, Siamak Daneshmand, Shahrokh F. Shariat
ObjectiveTo compare the value of flexible blue‐light cystoscopy (BLC) vs flexible white‐light cystoscopy (WLC) in the surveillance setting of non‐muscle‐invasive bladder cancer (NMIBC).MethodsAll major databases were searched for articles published before May 2023 according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement. The primary outcome was the accuracy
-
Fluorescence‐guided surgery using cetuximab‐800CW in patients with penile carcinoma BJU Int. (IF 4.5) Pub Date : 2024-04-25 Thomas S. Nijboer, Christa A. M. van der Fels, Jaron G. de Wit, Bas Keizers, Henrik K. Huizinga, Floris J. Voskuil, Maarten J. H. Voskamp, Marius C. van den Heuvel, Max J. H. Witjes, Igle Jan de Jong
ObjectiveTo investigate the feasibility of fluorescence molecular imaging (FMI), using cetuximab‐800CW, as an intraoperative tool to determine surgical margins in penile squamous cell carcinoma (PSCC).Patients and methodsA total of 11 patients with PSCC received 75 mg cetuximab followed by 15 mg cetuximab‐800CW 2 days before surgery. FMI of the whole excision specimen and tissue slices was performed
-
Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review BJU Int. (IF 4.5) Pub Date : 2024-04-25 Philipp Maisch, Eu Chang Hwang, Kwangmin Kim, Vikram M. Narayan, Caitlin Bakker, Frank Kunath, Philipp Dahm
ObjectivesTo assess the effects of immunotherapy compared to chemotherapy as first‐ and second‐line treatment of advanced or metastatic urothelial carcinoma.MethodsBased on a published protocol, we performed a systematic search of multiple databases. Two review authors independently performed the literature selection, identified relevant studies, assessed the eligibility of studies for inclusion, and
-
Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial BJU Int. (IF 4.5) Pub Date : 2024-04-25 Mifuka Ouchi, Takeya Kitta, Hiroki Chiba, Madoka Higuchi, Yui Abe‐Takahashi, Mio Togo, Naohisa Kusakabe, Sachiyo Murai, Hiroshi Kikuchi, Ryuji Matsumoto, Takahiro Osawa, Takashige Abe, Nobuo Shinohara
ObjectiveTo assess the effectiveness of pre‐ and postoperative supervised pelvic floor muscle training (PFMT) on the recovery of continence and pelvic floor muscle (PFM) function after robot‐assisted laparoscopic radical prostatectomy (RARP).Patients and MethodsWe carried out a single‐blind randomised controlled trial involving 54 male patients scheduled to undergo RARP. The intervention group started
-
Peri‐operative outcomes following radical prostatectomy in the setting of advanced prostate cancer BJU Int. (IF 4.5) Pub Date : 2024-04-24 Rishabh K. Simhal, Kerith R. Wang, Yash B. Shah, Costas D. Lallas, Mihir S. Shah, Thenappan Chandrasekar
ObjectiveTo compare the peri‐operative outcomes of radical prostatectomy (RP) for locally advanced, node‐positive, and metastatic prostate cancer (PCa), as determined through pathological staging, using the American College of Surgeons National Surgical Quality Improvement Project.MethodsWe identified RP procedures performed between 2019 and 2021. Patients were stratified by pathological staging to
-
Robot-assisted retrograde intrarenal surgery: first clinical experience with the ILY® system BJU Int. (IF 4.5) Pub Date : 2024-04-23 Alba Farré, Oriol Angerri, Andrés Kanashiro, Marta Casadevall, Alessandro Uleri, Josep Balañà, Francisco Sánchez Martin, Félix Millan, Joan Palou, Esteban Emiliani
-
-
Advances in cancer and a new antibiotic to treat complex UTIs BJU Int. (IF 4.5) Pub Date : 2024-04-22
-
-
‘Case of the Month’ from the Department of Urology, Oxford University Hospitals, Oxford, UK: stereotactic radiotherapy to the vas deferens for PSMA-PET CT detected local recurrence 10 years after radical prostatectomy BJU Int. (IF 4.5) Pub Date : 2024-04-22 Anthony S. Bates, Abhishek D. Sharma, Philip Camilleri, Lisa Browning, Clare Verrill, Freddie C. Hamdy
-
The Getting It right First Time (GIRFT) programme in urology; rationale and methodology BJU Int. (IF 4.5) Pub Date : 2024-04-18 Joseph B. John, William K. Gray, Kieran O'Flynn, Tim W.R. Briggs, John S. McGrath
The Getting It Right First Time (GIRFT) programme is a quality improvement initiative covering the National Health Service in England. The programme aims to standardise clinical practices and improve patient and system level outcomes by utilising data-driven insights and clinically-led recommendations. There are GIRFT workstreams for every medical and surgical specialty, including urology. Defining
-
Intra/inter-observer reliability of cystoscopic sphincter evaluation in men undergoing sling surgery BJU Int. (IF 4.5) Pub Date : 2024-04-16 Manuela Tutolo, Annouschka Laenen, Giuseppe Rosiello, Dirk De Ridder, Luk Bruyneel, Jan Cornelissen, Frank Van der Aa
To assess the intra/inter-observer reliability of cystoscopic sphincter evaluation (CSE) in men undergoing sling surgery for urinary incontinence and if possible to evaluate its correlation with the final clinical decision.
-
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancer BJU Int. (IF 4.5) Pub Date : 2024-04-16 Ekaterina Laukhtina, Paolo Gontero, Marko Babjuk, Marco Moschini, Jeremy Yuen-Chun Teoh, Morgan Rouprêt, Quoc-Dien Trinh, Piotr Chlosta, Péter Nyirády, Mohammad Abufaraj, Francesco Soria, Jakob Klemm, Kensuke Bekku, Akihiro Matsukawa, Shahrokh F. Shariat
To evaluate the impact of adjuvant therapy on oncological outcomes in patients with intermediate-risk non-muscle-invasive bladder cancer (NMIBC), as due to the poorly-defined and overlapping diagnostic criteria optimal decision-making remains challenging in these patients.
-
‘Case of the Month’ from the Department of Urology, Cottolengo Hospital, Torino, Italy: endoscopic combined intrarenal surgery (ECIRS) for a partial staghorn renal stone, one‐step solution using a new percutaneous basket BJU Int. (IF 4.5) Pub Date : 2024-04-16 Cesare M. Scoffone, Cecilia M. Cracco
-
-
Role of diverting colostomy and reconstruction in managing Fournier's gangrene—a narrative review BJU Int. (IF 4.5) Pub Date : 2024-04-16 Siyu Huang, David C. Chen, Marlon Perera, Nathan Lawrentschuk
ObjectiveTo examine the role of bowel diversion and reconstructive surgeries in managing Fournier's gangrene (FG) to facilitate multidisciplinary collaboration between urologists, colorectal and plastic surgery teams.MethodsA review of the literature was conducted using the databases Medline, Embase, PubMed in June 2023. The review included studies that evaluated the outcomes of FG following reconstructive
-
Trimodal therapy vs radical cystectomy in patients with muscle‐invasive bladder cancer: a systematic review and meta‐analysis of comparative studies BJU Int. (IF 4.5) Pub Date : 2024-04-16 Francesco Ditonno, Alessandro Veccia, Francesca Montanaro, Greta Pettenuzzo, Antonio Franco, Celeste Manfredi, Luca Triggiani, Cosimo De Nunzio, Marco De Sio, Mariangela Cerruto, Simone Crivellaro, Alexander Kutikov, Riccardo Autorino, Alessandro Antonelli
ObjectiveTo perform a systematic review and meta‐analysis of trials comparing trimodal therapy (TMT) and radical cystectomy (RC), evaluating differences in terms of oncological outcomes, quality of life, and costs.Materials and MethodsIn July 2023, a literature search of multiple databases was conducted to identify studies analysing patients with cT2‐4 N any M0 muscle‐invasive bladder cancer (MIBC;
-
Use of 18F‐fluoro‐2‐deoxy‐d‐glucose (18F‐FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients BJU Int. (IF 4.5) Pub Date : 2024-04-16 Mattia Longoni, Pietro Scilipoti, Chiara Re, Giuseppe Rosiello, Luigi Nocera, Francesco Pellegrino, Giuseppe Basile, Mario de Angelis, Leonardo Quarta, Giusy Burgio, Andrea Necchi, Antonio Cigliola, Arturo Chiti, Maria Picchio, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Marco Moschini
ObjectiveTo assess the diagnostic performance of 18F‐fluoro‐2‐deoxy‐d‐glucose (18F‐FDG) positron emission tomograpy (PET)/computed tomography (CT) in nodal staging before radical cystectomy (RC) and pelvic lymph node dissection (PLND) for bladder cancer (BCa).Materials and MethodsThis analysis was based on a cohort of 199 BCa patients undergoing RC and bilateral PLND between 2015 and 2022. Neoadjuvant
-
Population‐based study of disease trajectory after radical treatment for high‐risk prostate cancer BJU Int. (IF 4.5) Pub Date : 2024-04-15 Pär Stattin, Sarah Fleming, Xiwu Lin, Florence Lefresne, Sabine D. Brookman‐May, Suneel D. Mundle, Helen Pai, Dina Gifkins, David Robinson, Johan Styrke, Hans Garmo
ObjectivesTo investigate long‐term disease trajectories among men with high‐risk localized or locally advanced prostate cancer (HRLPC) treated with radical radiotherapy (RT) or radical prostatectomy (RP).Material and MethodsMen diagnosed with HRLPC in 2006–2020, who received primary RT or RP, were identified from the Prostate Cancer data Base Sweden (PCBaSe) 5.0. Follow‐up ended on 30 June 2021. Treatment
-
The FocAL therapy CONsensus (FALCON): enhancing partial gland ablation for localised prostate cancer BJU Int. (IF 4.5) Pub Date : 2024-04-13 Lara Rodríguez‐Sánchez, Robert Reiter, Alejandro Rodríguez, Mark Emberton, Theo de Reijke, Eva M. Compérat, Alberto Bossi, Rafael Sanchez‐Salas
-
Systematic review and network meta‐analysis of re‐intervention rates of new surgical interventions for benign prostatic hyperplasia BJU Int. (IF 4.5) Pub Date : 2024-04-11 Brian Ng Hung Shin, Liang Qu, Handoo Rhee, Eric Chung
ObjectiveTo assess the re‐intervention rates of new surgical benign prostatic hyperplasia (BPH) interventions, as the clinical durability of new surgical interventions for BPH is not widely known.MethodsA critical review of new surgical BPH therapies namely ‘UroLift®’, ‘Aquablation’, ‘Rezum’, ‘prostatic artery embolisation (PAE)’ and ‘temporary implantable nitinol device (iTIND)’ was performed on PubMed
-
How to improve penile cancer management by enhanced centralisation – learning from the Dutch example BJU Int. (IF 4.5) Pub Date : 2024-04-09 Matthias May, Anton Kravchuk, Steffen Lebentrau, Sabine Brookman‐May
-
Fully sexual‐sparing robot‐assisted cystectomy: a step‐by‐step surgical technique BJU Int. (IF 4.5) Pub Date : 2024-04-08 Chiara Vaccaro, Karel Dewulf, Konstantin Richter, Nicolas Branger, Stanislas Rybikowski, Thomas Maubon, Jochen Walz, Geraldine Pignot
-
Transdermal oestradiol and exercise in androgen deprivation therapy (ESTRACISE): protocol BJU Int. (IF 4.5) Pub Date : 2024-04-08 Ilkka Jussila, Juha P. Ahtiainen, Eija K. Laakkonen, Aino Siltari, Antti Kaipia, Tiina Jokela, Minta Kärkkäinen, Rob Newton, Truls Raastad, Heini Huhtala, Teemu J. Murtola, Heikki Seikkula
ObjectiveTo report the protocol of a study evaluating the efficacy of transdermal oestradiol (E2) gel in reducing the adverse effects of androgen deprivation therapy (ADT), specifically on sexual function, and to assess the utility of E2 in combination with supervised exercise.Study Design and MethodsThe primary endpoint of this open‐label Phase IIA randomized controlled trial is the efficacy of transdermal
-
Perspectives on technology – prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy? BJU Int. (IF 4.5) Pub Date : 2024-04-08 Christopher Berridge, Altan Omer, Francisco Lopez, Richard J. Bryant, Alastair D. Lamb
For many years, transrectal ultrasound‐guided (TRUS) prostate biopsies have been performed to establish a histological diagnosis of prostate cancer. This has been the recommended standard of care procedure, but has always carried risks, in particular the risk of post‐procedural sepsis, and the associated antibiotic burden and risk of development of antibiotic resistance. Transperineal (TP) prostate
-
Urethral cancer: a comprehensive review endorsed by the Global Society of Rare Genitourinary Tumours BJU Int. (IF 4.5) Pub Date : 2024-04-08 Herney Andrés García‐Perdomo, Angélica María Dávila‐Raigoza, Ellie Summers, Lucinda Billingham, Andrea Necchi, Gareth Griffiths, Philippe E. Spiess
ObjectiveTo determine the effectiveness and adverse effects of urethrectomy alone or as part of multimodal therapy (MMT).MethodsA comprehensive search was conducted across MEDLINE (OVID), EMBASE, LILACS and the Cochrane Central Register of Controlled Trials (CENTRAL) databases, from their inception to the present date. The study cohort comprised individuals aged 16 years and older diagnosed with urethral
-
Conservative management in high‐grade renal trauma: a systematic review and meta‐analysis BJU Int. (IF 4.5) Pub Date : 2024-04-03 Johannes Cansius Prihadi, Antoninus Hengky, Stevan Kristian Lionardi
ObjectiveTo systematically investigate and analyse the aggregated data from recent studies to provide a quantitative synthesis for a conservative approach to the management of high‐grade kidney trauma, as accumulating evidence supports the favourable outcomes of a conservative approach.MethodsA comprehensive search was performed using databases, including PubMed, EBSCO, ProQuest, Google Scholar, and
-
Endpoint and control group in prostate cancer screening research: public health basics BJU Int. (IF 4.5) Pub Date : 2024-03-30 Takeshi Takahashi
-
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’ BJU Int. (IF 4.5) Pub Date : 2024-03-30 Peter C. Albertsen
-
The utility of Martius fat pad in the repair of urogenital fistulae: review of current evidence BJU Int. (IF 4.5) Pub Date : 2024-03-28 Konstantinos Kapriniotis, Ioannis Loufopoulos, Helena C.M. Gresty, Tamsin J. Greenwell, Jeremy L. Ockrim
ObjectiveTo present the contemporary evidence on transvaginal urogenital fistulae (UGF) repair with Martius fat pad (MFP), compared to direct graftless fistula repair.MethodsWe reviewed all available studies reporting lower UGF repair via the transvaginal approach in MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). The primary outcome of interest was the fistula closure
-
Interaction of patient age and high‐grade prostate cancer on targeted biopsies of MRI suspicious lesions BJU Int. (IF 4.5) Pub Date : 2024-03-27 Jamie S. Pak, Richard Huang, William C. Huang, Herbert Lepor, James S. Wysock, Samir S. Taneja
ObjectivesTo evaluate the interaction of patient age and Prostate Imaging‐Reporting and Data System (PI‐RADS) score in determining the grade of prostate cancer (PCa) identified on magnetic resonance imaging (MRI)‐targeted biopsy in older men.Patients and methodsFrom a prospectively accrued Institutional Review Board‐approved comparative study of MRI‐targeted and systematic biopsy between June 2012
-
Correction to “Setting up a multi-disciplinary Klinefelter syndrome clinic – lessons learnt and shared” by S. Rintoul-Hoad et al. BJU Int. (IF 4.5) Pub Date : 2024-03-27
On page 59 of the Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia (BJU Int 2023; 131(S1): 4–82), a second affiliation for the author Ramzy Elnabarawy was omitted. The following has been added: 3Faculty of Medicine, Cairo University, Cairo, Egypt. We apologize for this error.
-
Prevalence of non‐neurogenic male lower urinary tract symptoms after kidney transplantation BJU Int. (IF 4.5) Pub Date : 2024-03-23 Alberto Costa Silva, Teresa Pina‐Vaz, Afonso Morgado, Carlos Martins‐Silva, Tiago Antunes‐Lopes, João Alturas Silva
ObjectiveThis review investigates the prevalence of male non‐neurogenic lower urinary tract symptoms (LUTS) after renal transplant, as kidney transplantation is a transformative intervention for patients with end‐stage renal disease significantly enhancing quality of life that might be diminished by LUTS.MethodsThe Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines were followed
-
Effect of detrusor underactivity on surgical outcomes of holmium laser enucleation of the prostate BJU Int. (IF 4.5) Pub Date : 2024-03-22 Hyun Ju Jeong, Hyomyoung Lee, Min Soo Choo, Sung Yong Cho, Seong Jin Jeong, Seung-June Oh
To evaluate the effect of detrusor underactivity (DUA) on the postoperative outcomes of holmium laser enucleation of the prostate (HoLEP) in patients with benign prostatic hyperplasia (BPH).
-
Screening and active surveillance in prostate cancer: the dilemma continues BJU Int. (IF 4.5) Pub Date : 2024-03-22 Freddie C. Hamdy, Peter C. Albertsen, Jenny L. Donovan
In this month's issue of the Journal, Takahashi questions the value of PSA screening because studies have failed to show a decline in overall mortality [1]. This is a very high public health standard as lethal prostate cancer is a relatively rare disease. Only 3% of men die from this disease annually in most Western countries, and demonstrating a meaningful decline in overall mortality requires studies
-
Reply to: Letter to the editor regarding the article ‘Prostate cancer outcomes following whole‐gland and focal high‐intensity focused ultrasound’ BJU Int. (IF 4.5) Pub Date : 2024-03-22 Matthew G. Parry, Arunan Sujenthiran, Julie Nossiter, Melanie Morris, Brendan Berry, Arjun Nathan, Ajay Aggarwal, Heather Payne, Jan van der Meulen, Noel W. Clarke
-
How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working Group BJU Int. (IF 4.5) Pub Date : 2024-03-21 Francesco Pellegrino, Alberto Martini, Ugo Giovanni Falagario, Juhana Rautiola, Antonio Russo, Laura S Mertens, Luca Di Gianfrancesco, Carlo Andrea Bravi, Jonathan Vollemaere, Muhammad Abdeen, Marco Moschini, Mikolaj Mendrek, Eirik Kjøbli, Stephan Buse, Carl Wijburg, Alae Touzani, Guillaume Ploussard, Alessandro Antonelli, Laura Schwenk, Jan Ebbing, Nikhil Vasdev, Gabriel Froelicher, Hubert John, Abdullah
Robot-assisted radical cystectomy (RARC) is a technically challenging procedure associated with high overall postoperative morbidity [1, 2]. Relative to other forms of urinary diversion, neobladder reconstruction is associated with a higher complication rate [3]. As low morbidity represents one of the pivotal surgical outcomes, efforts must be focused on minimizing the morbidity rate. To achieve this
-